OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism
Batoul Dia, Sahar Alkhansa, Rachel Njeim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 965-965
Open Access | Times Cited: 11
Batoul Dia, Sahar Alkhansa, Rachel Njeim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 965-965
Open Access | Times Cited: 11
Showing 11 citing articles:
Emerging role of antidiabetic drugs in cardiorenal protection
Wen-Jia Fu, Jin-Ling Huo, Zi‐Hui Mao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Wen-Jia Fu, Jin-Ling Huo, Zi‐Hui Mao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease
Zijing Zhu, Yun Cao, Yonghong Jian, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Zijing Zhu, Yun Cao, Yonghong Jian, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Mechanisms of Picrasma quassioides against hepatocellular carcinoma elucidated by network pharmacology and experimental validation
Jie Zhou, Zhilan Zhang, Riming Huang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1402-1415
Closed Access
Jie Zhou, Zhilan Zhang, Riming Huang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1402-1415
Closed Access
Shenzhuo formulation ameliorates diabetic nephropathy by regulating cytochrome P450-mediated arachidonic acid metabolism
Zhongyong Zhang, Yuming Wang, Ning Wang, et al.
World Journal of Diabetes (2025) Vol. 16, Iss. 5
Closed Access
Zhongyong Zhang, Yuming Wang, Ning Wang, et al.
World Journal of Diabetes (2025) Vol. 16, Iss. 5
Closed Access
Effects of empagliflozin and dapagliflozin, SGLT2 inhibitors, on miRNA expressions in diabetes-related cardiovascular damage in rats
H. Kiyak-Kırmacı, Ayşe Nur Hazar-Yavuz, Elif Beyzanur Polat, et al.
Journal of Diabetes and its Complications (2025), pp. 109063-109063
Closed Access
H. Kiyak-Kırmacı, Ayşe Nur Hazar-Yavuz, Elif Beyzanur Polat, et al.
Journal of Diabetes and its Complications (2025), pp. 109063-109063
Closed Access
Exploring the Protective Effects of Traditional Antidiabetic Medications and Novel Antihyperglycemic Agents in Diabetic Rodent Models
Cosmin Gabriel Tartau, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tarțău, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 670-670
Open Access
Cosmin Gabriel Tartau, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tarțău, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 670-670
Open Access
Integrating single‐cell transcriptomics and machine learning to predict breast cancer prognosis: A study based on natural killer cell‐related genes
Juanjuan Mao, Ling‐lin Liu, Qian Shen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 15
Open Access | Times Cited: 3
Juanjuan Mao, Ling‐lin Liu, Qian Shen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 15
Open Access | Times Cited: 3
A new perspective on proteinuria and drug therapy for diabetic kidney disease
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
O‐linked β‐N‐acetylglucosamine (O‐GlcNAc ) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy
Bingxue Qi, Yang Chen, Siyang Chai, et al.
Diabetic Medicine (2024)
Open Access | Times Cited: 2
Bingxue Qi, Yang Chen, Siyang Chai, et al.
Diabetic Medicine (2024)
Open Access | Times Cited: 2
Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety
Pei‐Ling Yu, Yu You, Shuang Li, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 7, pp. 1518-1530
Open Access | Times Cited: 1
Pei‐Ling Yu, Yu You, Shuang Li, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 7, pp. 1518-1530
Open Access | Times Cited: 1
Understanding Proteinuria in Patients with Diabetic Kidney Disease and Progress of Drug Therapy from a New Perspective
Ruimin Zhang, Qian Wang, Xuefeng Zhou, et al.
(2023)
Open Access | Times Cited: 2
Ruimin Zhang, Qian Wang, Xuefeng Zhou, et al.
(2023)
Open Access | Times Cited: 2
Vasoactive Substances as Mediators of Renal Injury
Paulo S. Caceres, Noreen F. Rossi
Elsevier eBooks (2024)
Closed Access
Paulo S. Caceres, Noreen F. Rossi
Elsevier eBooks (2024)
Closed Access
Advances in Clinical Diagnosis and Treatment of Diabetic Kidney Disease
思凝 陈
Advances in Clinical Medicine (2023) Vol. 13, Iss. 06, pp. 9426-9432
Closed Access
思凝 陈
Advances in Clinical Medicine (2023) Vol. 13, Iss. 06, pp. 9426-9432
Closed Access
